Covid: Blood cancer patients respond to booster dose rather than first dose - Hindustan Times

According to a recent study, less than half of patients with hematologic malignancies developed detectable antibodies after the initial Coid-19 vaccination, but 56 per cent of "nonresponders" developed antibodies after receiving a booster dose. | Health

According to a recent study, less than half of patients with hematologic malignancies developed detectable antibodies after the initial COVID-19 vaccination, but 56 per cent of "nonresponders" develo… [+2690 chars]

full article...